Technology can enable clinicians to assess patient's response to treatment accurately
WAUKESHA, Wisc. -- April 8, 2014 -- GE Healthcare, a unit of General Electric Company (NYSE: GE), today announced that it received U.S. FDA 510(k) clearance of its Q.Clear^ technology -- technology that can provide up to two times improvement in both quantitative accuracy and image quality in PET/CT imaging. This is an innovative new tool for clinicians across the entire care continuum including diagnosis, staging, treatment planning, and treatment assessment.
business unit
tags
CHALFONT ST. GILES, UK -- 24 March 2014 -- GE (NYSE:GE) announced today that it has completed the acquisition of Thermo Fisher's HyClone™ cell culture media and sera, and gene modulation and magnetic beads businesses. The acquisition allows GE to expand its offering of tools, technologies and services for the discovery and manufacture of innovative new medicines, vaccines and diagnostics in its growing Life Sciences business.
business unit
tags
Prototype device testing shows that GE's RF MEMS switch can help enable increased data transfer speeds, enhanced signal quality, longer battery life, and the advanced RF designs required of LTE-Advanced devices.
Videos demonstrating GE's MEMS technology available at: http://youtu.be/DXRsHjxHWEE and http://youtu.be/_RFBheVJbMs
business unit
tags
WAUKESHA, Wisc. -- Molecular Breast Imaging (MBI) Clinical Indications, Benefits and Challenges is the focus of a new CME credit course to be offered by ICPME® and funded in part by Gamma Medica, Inc. and in part by GE Healthcare. The one-hour online session will provide a thorough overview of MBI, which is a growing imaging technology for women with dense breasts and certain difficult-to-image cancers.